Craig Paterson
No más puestos en curso
Fortuna: 407 575 $ al 31/03/2024
Perfil
Actualmente, Craig Paterson es Director Médico de Allakos, Inc. Anteriormente fue Director Médico de Endo International Plc y Vicepresidente Senior de Desarrollo Médico y Clínico de Salix Pharmaceuticals Ltd. Se licenció en la Universidad McMaster y obtuvo un MBA en la Universidad de Tennessee.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
ALLAKOS, INC.
0.37% | 04/12/2023 | 323 472 ( 0.37% ) | 407 575 $ | 31/03/2024 |
Antiguos cargos conocidos de Craig Paterson.
Empresas | Cargo | Fin |
---|---|---|
ALLAKOS INC. | Chief Tech/Sci/R&D Officer | 09/02/2024 |
UMass Chan Medical School | Corporate Officer/Principal | - |
Vivelix Pharmaceuticalsc Corp. | Founder | - |
ENDO INTERNATIONAL PLC | Chief Tech/Sci/R&D Officer | - |
SALIX PHARMACEUTICALS, LTD. | Corporate Officer/Principal | - |
Formación de Craig Paterson.
McMaster University | Graduate Degree |
University of Tennessee | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ALLAKOS INC. | Health Technology |
Empresas privadas | 3 |
---|---|
Salix Pharmaceuticals Ltd.
Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Salix Pharmaceuticals Ltd. develops and commercializes prescription drugs and medical devices used in the treatment of gastrointestinal diseases, endocrinology, hepatology, colorectal surgery, and internal medicine. It offers Anusol, Apriso, Colazal, Deflux, Diuril, Fenoglide, MoviPrep, Pepcid, Solesta, and Zegerid. The company was founded by randy W. Hamilton and Lorin K. Johnson in1989 and is headquartered in Bridgewater, NJ. | Health Technology |
Endo International Plc
Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
Vivelix Pharmaceuticalsc Corp. |
- Bolsa de valores
- Insiders
- Craig Paterson